GE HealthCare Technologies
GEHC
64.67
-0.10
-0.15%
GE HealthCare Technologies
US · GEHC
#689 by market cap
Listed 2022
64.67
-0.10
-0.15%
Live - 5344 symbols - heartbeat 5s ago
· 2026-10-08 07:17
Pre-market
64.27
-0.62%
After-hours
64.67
0.00%
Overnight
64.55
-0.19%
- Market cap
- 29.21B
- P/E (TTM)i
- 14.90
- P/Bi
- 2.66
- EPSi
- 4.55
- Div yieldi
- 0.22%
- 52W posi
- 19%
Reader sentiment
Are you bullish or bearish on GEHC?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 14 analysts
Buy
Avg price target
80.71 +24.8%
Price target rangecurrent 64.67
Low71.00
Avg80.71
High93.00
Buy 71%
Hold 29%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-22 | Needham | -- | BUY | 93.00 |
| 2026-09-14 | BofA Securities | -- | HOLD | 74.00 |
| 2026-09-13 | BMO Capital | -- | HOLD | 71.00 |
| 2026-08-25 | Wells Fargo | -- | BUY | 85.00 |
| 2026-08-19 | BTIG | -- | BUY | 79.00 |
| 2026-08-13 | Citi | -- | HOLD | 75.00 |
| 2026-08-11 | BofA Securities | -- | HOLD | 74.00 |
| 2026-07-31 | UBS | -- | HOLD | 73.00 |
| 2026-07-31 | Mizuho Securities | -- | BUY | 85.00 |
| 2026-07-30 | Wells Fargo | -- | BUY | 85.00 |
| 2026-07-30 | Jefferies | -- | BUY | 92.00 |
| 2026-07-30 | Evercore | -- | BUY | 84.00 |
| 2026-07-30 | Stifel | -- | BUY | 80.00 |
| 2026-07-30 | Oppenheimer | -- | BUY | 85.00 |
| 2026-07-29 | BTIG | -- | BUY | 79.00 |
| 2026-07-29 | BofA Securities | -- | HOLD | 74.00 |
| 2026-07-29 | Citi | -- | HOLD | 75.00 |
| 2026-07-29 | RBC Capital | -- | BUY | 80.00 |
| 2026-07-24 | Piper Sandler | -- | BUY | 74.00 |
| 2026-07-24 | Stifel | -- | BUY | 80.00 |
| 2026-07-24 | Oppenheimer | -- | BUY | 85.00 |
| 2026-07-23 | Wells Fargo | -- | BUY | 75.00 |
| 2026-07-23 | BTIG | -- | BUY | 75.00 |
| 2026-07-16 | UBS | -- | HOLD | 67.00 |
| 2026-07-13 | BTIG | -- | BUY | 75.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: UBS moved from Sell to Hold on 2026-05-21.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-05-21 | UBS | SELL → HOLD | 69.00 |
| 2026-04-30 | Goldman Sachs | BUY → HOLD | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-29 | -- | ±7.19% | +12.15% (beat) |
| 2026/Q1 | 2026-04-29 | -- | ±5.56% | -13.16% (beat) |
| 2025/Q4 | 2026-02-04 | -- | ±4.87% | +4.89% (beat) |
| 2025/Q3 | 2025-10-29 | -- | ±5.39% | -2.54% (in line) |
| 2025/Q2 | 2025-07-30 | -- | ±6.87% | -7.82% (beat) |
| 2025/Q1 | 2025-04-30 | -- | ±7.65% | +3.29% (in line) |
| 2024/Q4 | 2025-02-13 | -- | ±5.93% | +8.82% (beat) |
| 2024/Q3 | 2024-10-30 | -- | ±6.37% | +2.26% (in line) |
| 2024/Q2 | 2024-07-31 | -- | ±7.96% | +2.40% (in line) |
| 2024/Q1 | 2024-04-30 | -- | ±5.50% | -14.28% (beat) |
| 2023/Q4 | 2024-02-06 | -- | ±4.86% | +11.65% (beat) |
| 2023/Q3 | 2023-10-31 | -- | ±5.19% | +5.38% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:17:36 · For reference only, not investment advice and not tailored to your situation.